Introduction

Risk-based biotechnology governance is a regulatory approach in which the level of oversight is determined by the nature, likelihood, and potential severity of risks associated with a biotechnology activity. Instead of applying identical restrictions to every innovation, regulators assess the characteristics of the organism or product, its intended use, exposure pathways, and possible effects on human health and the environment.

This approach is important because biotechnology includes a wide range of activities, from contained laboratory research to open-field trials and commercial release of genetically modified organisms (GMOs). A contained experiment may require different safeguards from an activity capable of affecting biodiversity or food systems on a large scale.

In India, risk-based governance is supported by the Environment (Protection) Act, 1986, and the Rules of 1989 governing genetically engineered organisms. It must also operate consistently with the precautionary principle, scientific evidence, public accountability, and constitutional protections of life and the environment.

Legal Framework and Case Laws

1. Vellore Citizens’ Welfare Forum v. Union of India, (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle as an essential component of sustainable development. It held that environmental authorities must anticipate and prevent environmental harm. Where serious or irreversible damage is threatened, lack of complete scientific certainty cannot justify postponing protective measures.

The Court also placed the burden on the developer or industrial actor to demonstrate that its activity is environmentally benign. This supports risk-based biotechnology governance because the intensity of safeguards should reflect the potential severity of harm, particularly where environmental effects may be irreversible.

Indian Kanoon+1

2. Gene Campaign v. Union of India, 2024 INSC 545

The Supreme Court examined the conditional environmental approval of genetically modified mustard (DMH-11), including biosafety assessment and regulatory oversight. The Court confirmed that decisions of GMO regulatory authorities are subject to judicial review.

The judgment highlighted the need for scientifically sound risk assessment, expert participation, and accountable decision-making. The Bench issued separate opinions and differed on the validity of the approval; the approval question was referred for fresh consideration. Therefore, the decision should not be described as a unanimous endorsement of GM mustard.

Indian Kanoon+1

3. A.P. Pollution Control Board v. Prof. M.V. Nayudu, (1999) 2 SCC 718

The Supreme Court emphasised the importance of scientific expertise in environmental decision-making, especially where technical uncertainty makes ordinary decision-making difficult. The case supports the use of independent expert assessment when determining the appropriate level of regulatory control.

Principles of Risk-Based Governance

A sound regulatory system should:

Classify activities according to their potential hazards and exposure.

Require stronger testing and containment for higher-risk activities.

Monitor approved activities and respond to new evidence.

Ensure transparency, expert review, and public accountability.

Apply proportionate restrictions without unnecessarily obstructing beneficial research.

Conclusion

Risk-based biotechnology governance seeks to balance scientific innovation with protection of health and the environment. The Vellore Citizens’ Welfare Forum decision supports precaution where serious harm is possible, while Gene Campaign demonstrates the importance of judicially reviewable and scientifically informed GMO regulation. A.P. Pollution Control Board v. Nayudu reinforces the role of expert knowledge. Together, these cases support a flexible but accountable system in which regulatory safeguards correspond to the risks posed by each biotechnology activity.

Indian Kanoon+1